GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardax Inc (OTCPK:CDXI) » Definitions » Cash per Share

Cardax (Cardax) Cash per Share : $0.07 (As of Mar. 2021)


View and export this data going back to 2012. Start your Free Trial

What is Cardax Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Cardax's Cash per Share for the quarter that ended in Mar. 2021 was $0.07.


Cardax Cash per Share Historical Data

The historical data trend for Cardax's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardax Cash per Share Chart

Cardax Annual Data
Trend Mar12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cash per Share
Get a 7-Day Free Trial Premium Member Only 0.37 3.65 0.36 0.03 0.02

Cardax Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.04 0.14 0.02 0.07

Cardax Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Cardax's Cash per Share for the fiscal year that ended in Dec. 2020 is calculated as:

Cardax's Cash per Share for the quarter that ended in Mar. 2021 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardax  (OTCPK:CDXI) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Cardax Cash per Share Related Terms

Thank you for viewing the detailed overview of Cardax's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardax (Cardax) Business Description

Traded in Other Exchanges
N/A
Address
2800 Woodlawn Drive, Suite 129, Honolulu, HI, USA, 96822
Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has applications in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.
Executives
Paulson Capital Corp 10 percent owner 222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142
Paulson Investment Company, Inc. 10 percent owner 5335 MEADOWS ROAD SUITE 465 LAKE OSWEGO OR 97035
Paulson Cardax Investments 1 Llc 10 percent owner 811 SW NAITO PKWY SUITE 300 PORTLAND OR 97204

Cardax (Cardax) Headlines

From GuruFocus

Cardax Voluntarily Suspends SEC Reporting Obligations

By PRNewswire PRNewswire 08-11-2021

Cardax Reports Q1 2019 Results

By PRNewswire PRNewswire 05-17-2019

Cardax Refocuses on ZanthoSyn� Consumer Health Business

By PRNewswire PRNewswire 08-31-2021

Cardax Announces Warrant Exchange Offer

By PRNewswire PRNewswire 05-03-2018

Cardax Reports 2017 Results

By PRNewswire PRNewswire 03-27-2018

Cardax Reports Q2 2020 Results

By PRNewswire PRNewswire 08-15-2020

Cardax Reports 2018 Results

By PRNewswire PRNewswire 03-28-2019